Praxis precision medicines to provide corporate update and report first quarter 2022 financial results on monday, may 9, 2022

Boston, may 02, 2022 (globe newswire) -- praxis precision medicines, inc. (nasdaq: prax), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (cns) disorders characterized by neuronal excitation-inhibition imbalance, today announced that it will provide a corporate update and report financial results for the first quarter 2022 on monday, may 9, 2022, after the u.s. financial markets close. management will provide a video update highlighting recent business and pipeline progress in conjunction with a press release. subsequently, management will host a separate q&a session via a live conference call and webcast at 4:30 p.m. et.
PRAX Ratings Summary
Quant
PRAX Quant Ranking
Sector
Industry
Quant Rating
Quant Score